Litcius/Paper detail

JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions

Takayuki Yoshino, G. Pentheroudakis, Saori Mishima, Michael J. Overman, Kun‐Huei Yeh, Eishi Baba, Yoichi Naito, Felipe A. Calvo, Ajit Kumar Saxena, L.-T. Chen, Masayuki Takeda, Andrés Cervantes, Hiroya Taniguchi, Kazuhiro Yoshida, Yasuhiro Kodera, Yuko Kitagawa, Josep Tabernero, Howard A. Burris, J.-Y. Douillard

2020Annals of Oncology140 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePembrolizumabMicrosatellite instabilityOncologyClinical trialCompanion diagnosticInternal medicineClinical OncologyCancerTrk receptorImmunotherapyReceptorNeurotrophinGeneMicrosatelliteAlleleBiochemistryChemistryGenetic factors in colorectal cancerLung Cancer Treatments and MutationsCancer Genomics and Diagnostics
JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions | Litcius